Skip to main content

Virilon Side Effects

Generic name: methyltestosterone

Medically reviewed by Drugs.com. Last updated on Nov 17, 2023.

Note: This document contains side effect information about methyltestosterone. Some dosage forms listed on this page may not apply to the brand name Virilon.

Applies to methyltestosterone: oral capsules, oral tablets.

Side effects include:

Males: Gynecomastia, frequent or persistent penile erections.

Females: Amenorrhea, other menstrual irregularities, inhibition of gonadotropin secretion, virilization (e.g., deepening of the voice, clitoral enlargement).

For Healthcare Professionals

Applies to methyltestosterone: compounding powder, oral capsule, oral tablet.

General

The more commonly reported adverse effects of androgen therapy in males is gynecomastia and excessive frequency and duration of penile erections; in women, virilization including voice deepening and clitoral enlargement.[Ref]

Cardiovascular

Frequency not reported: Edema with or without congestive heart failure, myocardial infarction, stroke

Postmarketing reports: venous thromboembolic events, including deep vein thrombosis (DVT)[Ref]

Endocrine

Frequency not reported: Gynecomastia, virilization (women), hirsutism[Ref]

Hepatic

Rare (less than 0.1%): Peliosis hepatic

Frequency not reported: Cholestatic jaundice, altered liver function[Ref]

Genitourinary

Frequency not reported: Amenorrhea, menstrual irregularities, excessive frequency and duration of penile erections, oligospermia, increased or decreased libido[Ref]

Metabolic

Frequency not reported: Retention of sodium, chloride, water, potassium, calcium and inorganic phosphates, increased serum cholesterol, hypercalcemia[Ref]

Dermatologic

Frequency not reported: Male pattern baldness, acne[Ref]

Gastrointestinal

Frequency not reported: Nausea, vomiting[Ref]

Musculoskeletal

Frequency not reported: acceleration of bone maturation without producing compensatory gain in linear growth resulting in compromised adult stature[Ref]

Hematologic

Frequency not reported: Suppression of clotting factors II, V, VII, and X; bleeding (in patients on concomitant anticoagulant therapy and polycythemia)[Ref]

Hypersensitivity

Very rare (less than 0.01%): Anaphylactoid reactions[Ref]

Nervous system

Frequency not reported: Headache, generalized paresthesia[Ref]

Oncologic

Rare (less than 0.1%): Hepatocellular neoplasms[Ref]

Respiratory

Postmarketing reports: venous thromboembolic events, including pulmonary embolism[Ref]

Psychiatric

Frequency not reported: Steroid abuse, anxiety, depression

References

1. Product Information. MethylTESTOSTERone (methylTESTOSTERone). Impax Generics. 2022.

2. Product Information. Android (methylTESTOSTERone). ICN Pharmaceuticals Inc. PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.